Outcome of Board Meeting

TAVEXIA LIFECARE LIMITED (FORMERLY SATTVA SUKUN LIFECARE LIMITED) CIN: L27509MH1980PLC329224 Date: 04/11/2026 BSE Limited Department of Corporate Services, Ground Floor, P.J. Tower, Dalal Street, Mumbai-400 001 Scrip ID – TAVEXIA Scrip Code: 539519 Subject: Outcome of Board Meeting of the Company held on today i.e. Wednesday 04th November 2026 Dear Sir/Madam, In compliance with Regulations 30 and 33 read with Para A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any statutory modification(s), amendment(s)and re-enactment(s) thereof, this is to inform you that the Board of Directors of the Company at their meeting held on today i.e. Wednesday 04th November 2026 at its registered office at Office Plot No. 2B/1, Ground Floor, Kandivali Cooperative Industrial Estate Ltd., Hindustan Naka, Kandivali (West), Mumbai – 400067 transacted following matters: 1. Approved the Un-Audited Financial Results (Standalone and consolidated) for the Quarter and half year ended September 30, 2026, Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015. 2. Approved and took on the record the Limited Review Report on the Un-Audited Financial Results (Standalone and consolidated) for the Quarter and half year ended September 30, 2026, issued by Statutory Auditors of the Company M/s DEVAM & Associates LLP, Chartered Accountants. 3. Considered and take on record, Statement of deviation(s) or variation (s), Pursuant to Regulation 32 of SEBI (LODR) Regulation, 2015, on use of proceeds from the objects stated in the Right issue offer document. 4. Change in Registrar & Transfer Agent (RTA) of the Company from Niche Technologies Pvt. Ltd (“Niche”) to Skyline Financial Services Pvt. Ltd (“Skyline”). Niche will continue to serve as the Company’s RTA until the completion of data transition, shifting of electronic connectivity, and other related procedures, along with receipt of necessary confirmations/ approval from NSDL, CDSL and other authority, if any. The formalities for change of RTA including documentation, execution of agreement, shifting of electronic connectivity and transition of data will be done by the Company in due course. The details as required in terms of Regulation 30 of SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026, is enclosed as Annexure - A. 5. Approval of Proposal for Raising of Funds through Issuance of Securities The Board of Directors considered and discussed the proposal for raising funds to finance the proposed acquisition of 60% of the equity share capital of Meyonex Pharmaceuticals Limited, as approved by board of directors in its meeting dated 07th October, 2026. Mumbai Office: Plot No. 2B/1, Ground Floor, Kandivali Cooperative Industrial Estate Ltd., Hindustan Naka, Kandivali (West), Mumbai – 400067 Tel: +91-22-2868 4491 | Email: info@mayukh.co.in & sattvasukunlifecarelimited@gmail.com| Website: www.mayukh.co.in & https://sattvasukun.co.in/ TAVEXIA LIFECARE LIMITED (FORMERLY SATTVA SUKUN LIFECARE LIMITED) CIN: L27509MH1980PLC329224 In this regard, the Board discussed the proposal to raise funds through such appropriate modes as may be considered suitable, including a preferential issue of securities, a rights issue of equity shares, or any other permissible mode of issuance of securities, for an aggregate amount not exceeding ₹68,00,00,000/- (Rupees Sixty- Eight Crores Only) in one or more trenches, in accordance with the applicable provisions of law, including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended from time to time. After due deliberation, the Board accorded its in-principle approval and authorised the Executive Directors of the Company to appoint such consultants, professionals, intermediaries, valuers and other experts as may be required to evaluate and recommend the most appropriate mode and type of securities issuance for raising the aforesaid funds. The Board further noted that the final decision regarding the mode, structure, terms and conditions of the proposed fund raising shall be considered and approved at a subsequent meeting of the Board, subject to applicable statutory and regulatory requirements. Additional Disclosure for Fund Raising through Issuance of Securities will be given at the time of final decision will be taken by board of directors. The aforesaid Board Meeting commenced at 06.30 P.M. and concluded at 09:20 P.M. Please take the same on your record and acknowledge the receipt of the same Thanking You, Yours Faithfully For Tavexia Lifecare Limited (Formerly Sattva Sukun Lifecare) Poonam Rani Company Secretary Mumbai Office: Plot No. 2B/1, Ground Floor, Kandivali Cooperative Industrial Estate Ltd., Hindustan Naka, Kandivali (West), Mumbai – 400067 Tel: +91-22-2868 4491 | Email: info@mayukh.co.in & sattvasukunlifecarelimited@gmail.com| Website: www.mayukh.co.in & https://sattvasukun.co.in/ TAVEXIA LIFECARE LIMITED (FORMERLY SATTVA SUKUN LIFECARE LIMITED) CIN: L27509MH1980PLC329224 Annexure A Date: 04/11/2026 BSE Ltd. Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001 Script ID: TAVEXIA Scrip Code: 539519 Subject: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) – Intimation of Change in Registrar and Share Transfer Agent (“RTA”) Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III thereto and SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026, last updated on January 30, 2026, we hereby inform you the Board of Directors at its meeting held today, approved the change of Registrar and Share Transfer Agent (‘RTA’) for listed equity shares of the Company from Niche Technologies Pvt. Ltd (“Niche”) to Skyline Financial Services Pvt. Ltd (“Skyline”). Further, we also wish to inform you that Niche Technologies Pvt. Ltd will continue to serve as the Company’s RTA until the completion of data transition, shifting of electronic connectivity and other related procedures, along with receipt of necessary confirmation from National Securities Depository Limited and Central Depository Services Limited. The details as required in terms of Regulation 30 of SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026 are as under: Sr. No. Particulars Details 1. Reason for appointment or Skyline Financial Services Pvt. Ltd (“Skyline”) has discontinuation technologically advanced infrastructural framework to provide quick and quality services, presence, capacity to align with share registry activities and wider reach to the shareholders’ base. 2. Date on which above would become The effective date of the aforesaid change will be intimated effective separately after carrying out necessary procedures and documentation. Kindly take the same on record. For Tavexia Lifecare Limited (Formerly Sattva Sukun Lifecare Limited) Poonam Rani Company Secretary Registered Office: Plot No. 2B/1, Ground Floor, Kandivali Cooperative Industrial Estate Ltd., Hindustan Naka, Kandivali (West), Mumbai – 400067 Tel: +91-22-2868 4491 | Email: info@mayukh.co.in & sattvasukunlifecarelimited@gmail.com| Website: www.mayukh.co.in & https://sattvasukun.co.in/ www.tavexia.com LIMITED REVIEW REPORT Independent Auditors’ Report on Standalone Quarter and half-year ended Unaudited Financial Results of TAVEXIA LIFECARE LIMITED (Formerly known as Sattva Sukun Lifecare Limited) for the quarter and half-year ended 30/09/2026 of the company pursuant to Regulation 33 and Regulations 52 read with Regulation 63(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors, TAVEXIA LIFECARE [Showing first 8,000 characters — download PDF for full document]